These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 34508355)

  • 21. A role of intracellular mono-ADP-ribosylation in cancer biology.
    Scarpa ES; Fabrizio G; Di Girolamo M
    FEBS J; 2013 Aug; 280(15):3551-62. PubMed ID: 23590234
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studying Catabolism of Protein ADP-Ribosylation.
    Palazzo L; James DI; Waddell ID; Ahel I
    Methods Mol Biol; 2017; 1608():415-430. PubMed ID: 28695524
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural insights into DarT toxin neutralization by cognate DarG antitoxin: ssDNA mimicry by DarG C-terminal domain keeps the DarT toxin inhibited.
    Deep A; Singh L; Kaur J; Velusamy M; Bhardwaj P; Singh R; Thakur KG
    Structure; 2023 Jul; 31(7):780-789.e4. PubMed ID: 37167974
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ADP-ribosylhydrolases: from DNA damage repair to COVID-19.
    Yu L; Liu X; Yu X
    J Zhejiang Univ Sci B; 2021 Jan; 22(1):21-30. PubMed ID: 33448184
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective monitoring of the protein-free ADP-ribose released by ADP-ribosylation reversal enzymes.
    Kasson S; Dharmapriya N; Kim IK
    PLoS One; 2021; 16(6):e0254022. PubMed ID: 34191856
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The structure of human ADP-ribosylhydrolase 3 (ARH3) provides insights into the reversibility of protein ADP-ribosylation.
    Mueller-Dieckmann C; Kernstock S; Lisurek M; von Kries JP; Haag F; Weiss MS; Koch-Nolte F
    Proc Natl Acad Sci U S A; 2006 Oct; 103(41):15026-31. PubMed ID: 17015823
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ADP-ribosylation of RNA in mammalian cells is mediated by TRPT1 and multiple PARPs.
    Weixler L; Feijs KLH; Zaja R
    Nucleic Acids Res; 2022 Sep; 50(16):9426-9441. PubMed ID: 36018800
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ADP-Ribosylation, a Multifaceted Posttranslational Modification Involved in the Control of Cell Physiology in Health and Disease.
    Lüscher B; Bütepage M; Eckei L; Krieg S; Verheugd P; Shilton BH
    Chem Rev; 2018 Feb; 118(3):1092-1136. PubMed ID: 29172462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Players in ADP-ribosylation: Readers and Erasers.
    Verheugd P; Bütepage M; Eckei L; Lüscher B
    Curr Protein Pept Sci; 2016; 17(7):654-667. PubMed ID: 27090904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. State of the art of protein mono-ADP-ribosylation: biological role and therapeutic potential.
    Fabrizio G; Scarpa ES; Di Girolamo M
    Front Biosci (Landmark Ed); 2015 Jan; 20(3):405-30. PubMed ID: 25553458
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hydrolysis of ADP-Ribosylation by Macrodomains.
    Posavec Marjanovic M; Jankevicius G; Ahel I
    Methods Mol Biol; 2018; 1813():215-223. PubMed ID: 30097870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ADP-ribosylarginine hydrolases and ADP-ribosyltransferases. Partners in ADP-ribosylation cycles.
    Moss J; Zolkiewska A; Okazaki I
    Adv Exp Med Biol; 1997; 419():25-33. PubMed ID: 9193633
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A family of macrodomain proteins reverses cellular mono-ADP-ribosylation.
    Jankevicius G; Hassler M; Golia B; Rybin V; Zacharias M; Timinszky G; Ladurner AG
    Nat Struct Mol Biol; 2013 Apr; 20(4):508-14. PubMed ID: 23474712
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of DNA ADP-ribosyltransferase activities of PARP2 and PARP3: new insights into DNA ADP-ribosylation.
    Zarkovic G; Belousova EA; Talhaoui I; Saint-Pierre C; Kutuzov MM; Matkarimov BT; Biard D; Gasparutto D; Lavrik OI; Ishchenko AA
    Nucleic Acids Res; 2018 Mar; 46(5):2417-2431. PubMed ID: 29361132
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ART2, a T cell surface mono-ADP-ribosyltransferase, generates extracellular poly(ADP-ribose).
    Morrison AR; Moss J; Stevens LA; Evans JE; Farrell C; Merithew E; Lambright DG; Greiner DL; Mordes JP; Rossini AA; Bortell R
    J Biol Chem; 2006 Nov; 281(44):33363-72. PubMed ID: 16931513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Promise of Proteomics for the Study of ADP-Ribosylation.
    Daniels CM; Ong SE; Leung AK
    Mol Cell; 2015 Jun; 58(6):911-24. PubMed ID: 26091340
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemical ADP-ribosylation: mono-ADPr-peptides and oligo-ADP-ribose.
    Liu Q; van der Marel GA; Filippov DV
    Org Biomol Chem; 2019 Jun; 17(22):5460-5474. PubMed ID: 31112180
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of nitrogenase by reversible mono-ADP-ribosylation.
    Moure VR; Costa FF; Cruz LM; Pedrosa FO; Souza EM; Li XD; Winkler F; Huergo LF
    Curr Top Microbiol Immunol; 2015; 384():89-106. PubMed ID: 24934999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The ARH and Macrodomain Families of α-ADP-ribose-acceptor Hydrolases Catalyze α-NAD
    Stevens LA; Kato J; Kasamatsu A; Oda H; Lee DY; Moss J
    ACS Chem Biol; 2019 Dec; 14(12):2576-2584. PubMed ID: 31599159
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanism of ADP-ribosylation removal revealed by the structure and ligand complexes of the dimanganese mono-ADP-ribosylhydrolase DraG.
    Berthold CL; Wang H; Nordlund S; Högbom M
    Proc Natl Acad Sci U S A; 2009 Aug; 106(34):14247-52. PubMed ID: 19706507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.